Latest News about RDY
Recent news which mentions RDY
Top 5 Health Care Stocks That May Fall Off A Cliff
August 23, 2023
From Benzinga
Why Are Journey Medical Shares Trading Lower Today?
July 11, 2023
From Benzinga
Why Are Journey Medical Shares Trading Higher Today
June 13, 2023
From Benzinga
The 3 Most Undervalued Value Stocks to Buy in June 2023
June 04, 2023
From InvestorPlace
Why Aditxt Shares Are Surging Today
April 20, 2023
From Benzinga
From Benzinga
From Benzinga
Dr. Reddy's Seeks Gaining Foothold In Women's Health Via Mayne Pharma's U.S. Generic Prescription Deal
February 27, 2023
From Benzinga
The 3 Most Undervalued Stocks in India for Your February Buy List
January 31, 2023
From InvestorPlace
Journey Medical Touts Positive PK Data For Bacterial Infection Candidate
December 20, 2022
From Benzinga
Novartis Fails To Prevent Generic Competition For Its Blockbuster Multiple Sclerosis Drug
October 14, 2022
From Benzinga
Intercept Settles Ocaliva Litigation With Reddy's Lab
August 17, 2022
From Benzinga
Biotech Daily: Thumbs Down For Acadia's Antipsychotic Drug, Akebia Fails COVID-19 Study, Kazia's Encouraging Data In Brain Metastases
August 05, 2022
From Benzinga
From Benzinga
From InvestorPlace
From Benzinga
From Benzinga
Dr. Reddy's Laboratories & MediCane Health To Launch Medical Cannabis Products In Germany
April 01, 2022
Tickers
RDY
From Benzinga
Stocks That Hit 52-Week Lows On Wednesday
March 02, 2022
From Benzinga
Stocks That Hit 52-Week Lows On Tuesday
March 01, 2022
From Benzinga
NYSE-Listed Pharma Co. Dr. Reddy's To Acquire German Medical Cannabis Firm Nimbus Health GmbH
February 04, 2022
Tickers
RDY
From Benzinga
Earnings Scheduled For January 28, 2022
January 28, 2022
From Benzinga
From Benzinga
Why BioDelivery Sciences International Stock Was Up 28.5% Monday
December 20, 2021
From Motley Fool
Dr. Reddy's Ready To Make COVID-19 Antiviral From Pfizer - Reuters
November 16, 2021
From Benzinga
From Benzinga
The success of Merck’s antiviral—and other COVID-19 pills in development—may depend on how quickly people start taking them
October 14, 2021
From MarketWatch
Indian Study Shows Merck's COVID-19 Antiviral Candidate Less Effective Against Moderate Infection: Reuters
October 08, 2021
From Benzinga
Why This Citius Analyst Thinks The Biopharma's Shares Present 375% Upside Potential
September 10, 2021
From Benzinga
Dr Reddy's To Sell Its Anti-Cancer Agent To Citius Pharma
September 07, 2021
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
